Information About Covid-19 (新型コロナウイルス感染症情報)

更新日:2024年11月28日

ページID: 10693

Latest Information

About COVID-19 Vaccines

As of FY 2024, COVID-19 vaccines will be carried out as routine vaccinations for older adults. Eligible people are those age 65+ on the day of the vaccination, and those between the ages of 60-64 on the day of the vaccination with heart, kidney, or respiratory diseases, or those with immune system deficiencies due to HIV and who hold a class 1 disability certificate. Eligible people should've gotten their vaccine tickets around the end of September by mail. 

Those who are ineligible (due to younger age or not having the applicable health conditions) can take the vaccine on a voluntary basis. In this case, the person taking the vaccine will have to bear the full cost. (Nationally, this is about 15,300 yen, but this will vary a bit by healthcare center.)

Please see the Japanese-language page for all the details:

About the Management of COVID-19 from April 2024 Onward

Notice for All City Residents

This is an announcement from Iwate prefecture.
As of March 31st, 2024, in light of the reevaluation of the national system, public funding support for the cost of medications and hospital stays related to COVID-19 will come to an end; the burden of medical fees will change.

Things That Will End as of April 2024

  • As of the end of March, the designation of outpatient medical facilities for diagnosis/consultations for people with fevers will come to an end. If you have a fever or similar symptoms, please go to your regular doctor or a local healthcare center.
    (Note) You can search for healthcare centers within the prefecture via Iwate Medical Net.

  • Public funding support for the out-of-pocket portion of high-cost medical care for hospital stays will conclude at the end of March.

  • Vaccine-related public funds will be discontinued at the end of March.

  • Public funds for COVID-19 medications (Lagevrio, Paxlovid, Xocova, etc.) will be discontinued at the end of March.

Things That Will Continue After April 2024

The consultation center for people with fevers (the Iwate Healthcare Follow-up Center) and the Iwate Prefecture COVID-19 Vaccine Expert Consultation Line will be run as the Prefectural Residents’ Medical Consultation Center (weekdays 9AM-4PM) and the Iwate Fever Consultation Center (weekdays 4PM-9AM the next day, weekends/holidays, and new year's holiday.)

COVID-19 is Spreading in Iwate. Please Keep Taking Basic Measures to Stop the Spread of New Infections

About the Transmission Trends of Covid-19 etc. in Iwate and Oshu

The transmission trend of Covid-19 in Oshu is as follows.

Report timeframe: Week 47 (November 18th - November 24th)
Infected persons per unit was 7.86, a decrease as compared to the previous week (9.57), but there is a trend of increases across the prefecture.

Viral activity will increase during the upcoming season. So as to protect older adults and others with a higher risk of serious infection, and to avoid putting strain on the healthcare system due to the spread of new infections, please continue to take basic preventative measures: such as avoiding the 3 C’s, leaving space between yourself and others, washing your hands/practicing hand hygiene, effective ventilation, wearing a mask when the situation calls for it, and similar.

If you have a fever or other symptoms, please consult your regular doctor or your nearest healthcare center for treatment. If you don't have a regular doctor or are unsure which healthcare center to contact, please reach out to the Prefectural Residents’ Medical Consultation Center or the Iwate Fever Consultation Center.

Prefectural Residents’ Medical Consultation Center (weekdays/daytime, 9:00AM - 4:00PM)
Phone: 019-629-9620
Fax: 019-626-0837

Iwate Fever Consultation Center (nighttime 4:00PM-9:00AM the next day, weekends/holidays, and New Year's holiday)
Phone: 0570-059-333
Fax: 050-3816-3649

You can access COVID-19 infection trend data from this page (Japanese-language only):

https://www2.pref.iwate.jp/~hp1353/kansen/

Older & Other Information